Klor-con and Status epilepticus - a phase IV clinical study of FDA data

Summary:

Status epilepticus is reported as a side effect among people who take Klor-con (potassium chloride), especially for people who are female, 50-59 old, also take Lyrica, and have Epilepsy.

The phase IV clinical study analyzes which people have Status epilepticus when taking Klor-con. It is created by eHealthMe based on reports of 27,036 people who have side effects when taking Klor-con from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Status epilepticus?

Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure) is found to be associated with 668 drugs and 949 conditions by eHealthMe. Check the latest studies of Status epilepticus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

27,036 people reported to have side effects when taking Klor-con.
Among them, 13 people (0.05%) have Status epilepticus.

Could Klor-con cause Status epilepticus?

Among these 13 people:

What is the gender of people who have Status epilepticus when taking Klor-con? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Status epilepticus when taking Klor-con? *

What are other drugs people take besides Klor-con? *

What are other side effects people have besides Status epilepticus? *

Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 53.85%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 7 people, 53.85%
Consciousness - Decreased: 6 people, 46.15%
Euphoric Mood (excessively happy but may become angry or irritable): 6 people, 46.15%
Feeling Drunk: 6 people, 46.15%
Corneal Disorder: 6 people, 46.15%
Visual Acuity Reduced (reduced clearness of vision): 6 people, 46.15%
Vision Blurred: 6 people, 46.15%
Blood Disorder: 6 people, 46.15%
Sweat Gland Disorder: 6 people, 46.15%

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 8 people, 61.54%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 6 people, 46.15%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 15.38%
Pain: 2 people, 15.38%
Dyspnea (difficult or laboured breathing): 2 people, 15.38%
Gait Disturbance: 1 person, 7.69%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 7.69%
Cardiac Disorder: 1 person, 7.69%
Constipation: 1 person, 7.69%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and have Status epilepticus?

- Check whether Status epilepticus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Klor-con:

Klor-con (27,547 reports)

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Status epilepticus:

Status epilepticus (668 drugs)

Browse all the conditions that are associated with Status epilepticus:

Status epilepticus (949 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Klor-con) and Klor-con (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.